Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
A new breed of trading platform promises 24/7 tokenized stock access and self-clearing tech. This deep dive explains ...
A growing share of homeowners won’t sell price—and that stance is reshaping markets. This article explains how small ...
AST SpaceMobile faced a sharp weekly drop after announcing a large convertible debt raise. This article explains why ...
A family faced a costly mystery when a $50,000 cashier’s check vanished in transit. This guide breaks down how these ...
Looking for reliable income and diversification in 2026? These best Vanguard bond picks offer a practical path with c...
A single insider sale coincided with a sharp move lower in Sprinklr’s shares, prompting questions about signal versus...
Bitcoin's renewed drop pulled Strategy, BitMine, and Robinhood shares toward monthly lows. This article breaks down w...
Retirement is a high-stakes puzzle. Learn practical strategies to coordinate social security, RMDs, and Roth conversi...
Bitcoin has reached 20 million mined, a landmark that marks 95% of the capped supply. The milestone sharpens debate o...